Currently browsing: MPN ADVOCATES NETWORK
MPN-adv logo

HULL DONOSI MPN ADVOCATES NETWORK NEWSLETTER ZA PROSINAC 2021.

  MPN Advocates Network, December 2021   MPN HZ Virtual Conference 2021 This year, MPN Advocates Network (MPN AN) had the 6th International MPN Horizons Virtual Conference 2021 which attracted high interest with more than 150 registrations from 50 countries from all over the world. The 6th MPN Horizons Conference Programme consisted of 3 half days with around 60 daily...

MPN-logo

PRENOSIMO OBJAVU MPN RESEARCH FOUNDATION-A U nastavku možete pročitati dopis MPN RESEARCH FOUNDATION-A, gđe. Kamile Viges, a koji se odnosi na planove te međunarodne organizacije u idućoj godini.

What's next? At the end of a productive meeting, day, or week, I'm always asking myself, "what's next." Next on my calendar, next on my list, next on the agenda. Last year, I recognized that to get to what's next as a foundation, I first had to learn, listen, and prepare.   I learned about the foundation's core research mission...

MPN-adv logo

HULL PRENOSI OBJAVU MPN ADVOCATES NETWORKA O MPN (MIJELOPROLIFERATIVNE NEROPLAZME) – NOVOSTI S ASH-A 2021.

U nastavku možete poslušati ekskluzivni interview s profesorom Rubenom Mesa, koji govori o najnovijim novostima s ASH-a 2021., a odnose se na MPN – mijeloproliferativne neoplazme. MPN News from ASH 2021 Dear MPN Advocate Network Community, We are thrilled to share with you the latest MPN News from ASH 2021. Please take a moment to listen to the exclusive interview...

MPN

HULL DONOSI BILTEN MPN RESOURCH FOUNDATION-A ZA MJESEC LIPANJ 2021. – POGLEDAJTE PREDAVANJE DR. SRĐANA VERSTOVŠEKA

Conference Highlights   Two significant conferences for the oncology and hematology research communities took place this month and each featured important content on MPNs.   At the American Society of Clinical Oncology's (ASCO) 2021 Annual Meeting, the MPN research presented included updates on several significant clinical trials for MF, including SIMPLIFY-1 (Momelotinib, Sierra Oncology) and BOREAS (KRT-232, Kartos Therapeutics). BOREAS is a new phase 3 study designed...

IMG_4018

HULL na MPN Horizons 2017.

U Frankfurtu se od 27. do 29. listopada 2017. održala 2. međunarodna konferencija udruga koje predstavljaju osobe s mijeloproliferativnim neoplazmama MPN Horizons 2017. Na konferenciji je sudjelovala i Hrvatska udruga leukemija i limfomi koju je predstavljao naš član Kristian Lewis. Mijeloproliferativne neoplazme skupni je naziv za rijetke bolesti kao što su policitemija vera, primarna mijelofibroza, esencijalna trombocitemija i kronična mijeloična...